CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 708 enrolled
Drug / intervention
Walnuts +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01634841
NCT01634841N/ACompleted
CompareCT.gov

Effect of Daily Ingestion of Walnuts for 2 Years on Age-related Cognitive Decline and Macular Degeneration in Healthy Elderly Subjects: A Randomized, Single Blind, Dual Center, Controlled Trial

Loma Linda University·interventional·Posted Jul 6, 2012·Updated Jun 24, 2021

In Brief

A clinical study evaluating Walnuts and habitual diet for Age Related Cognitive Decline and Age Related Macular Degeneration. Completed, enrolled 708 participants across 2 sites in 2 countries.

Detailed Summary

This will be a systematic investigation of the role of walnuts in preventing or slowing age related cognitive decline and age related macular degeneration. 700 subjects will be recruited between 2 sites, Loma Linda University in California, USA and Hospital Clinic in Barcelona, Spain. Participants will be randomly assigned to either the walnut group or the control group for a 2 year intervention. Baseline and annual data will be collected and analyzed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAge Related Cognitive Decline, Age Related Macular Degeneration
CountriesSpain, United States
CollaboratorsUniversity of Barcelona, California Walnut Commission

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 6, 2012
Enrollment StartApr 1, 2012
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 14.0 years ago

Interventions

Walnutsdietary

30 to 60g (1 to 2 oz) per day of walnuts

habitual dietother

Dietary information will be provided